Rheumatology 2000; 39: 821-834
© 2000 British Society for Rheumatology
Reviews |
Advances in our understanding of the bone and joint pathology caused by Staphylococcus aureus infection
Cellular Microbiology Research Group, Division of Surgical Sciences, Eastman Dental Institute, University College London, London, UK
| The first 150 words of the full text of this article appear below. |
| Introduction |
|---|
There is growing concern that we are entering a bacteriological dark age in which we will no longer be able to treat bacterial infections with antibiotics. This apocalyptic prophecy is fuelled by the increasing incidence of antibiotic-resistant bacteria, and perhaps the best example of how we are losing the antibiotic battle is provided by Staphylococcus aureus [1], which has been reported recently to have become less susceptible to vancomycin, the antibiotic of last resort [2, 3]. S. aureus causes a range of bone and joint pathologies, such as infections of prostheses, osteomyelitis, septic arthritis and septic bursitis. The reported incidence of infection of prosthetic joints is 15%, and although this figure may appear to be low, the consequences of infections are dire [4, 5]. Prosthetic implant infections are usually treated by revision operations because the success rate for treatment without revision, at
| The role of virulence factors in S. aureus-induced bone and joint pathology |
|---|
| Capsular polysaccharide |
|---|
| Lipoteichoic acid and peptidoglycan |
|---|
| Microbial surface components recognizing adhesive matrix molecules |
|---|
| Coagulase |
|---|
| Protein A |
|---|
| Exotoxins |
|---|
| Enzymes |
|---|
| Regulation of virulence factor production by S. aureus and its effects on bone and joint pathology |
|---|
| S. aureus invasion of host cells: a role in bone and joint pathology? |
|---|
| Host factors important in S. aureus-induced bone and joint pathology |
|---|
| Conclusions |
|---|
This article has been cited by other articles:
![]() |
R. Guo, M. Yamashita, Q. Zhang, Q. Zhou, D. Chen, D. G. Reynolds, H. A. Awad, L. Yanoso, L. Zhao, E. M. Schwarz, et al. Ubiquitin Ligase Smurf1 Mediates Tumor Necrosis Factor-induced Systemic Bone Loss by Promoting Proteasomal Degradation of Bone Morphogenetic Signaling Proteins J. Biol. Chem., August 22, 2008; 283(34): 23084 - 23092. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kaneki, R. Guo, D. Chen, Z. Yao, E. M. Schwarz, Y. E. Zhang, B. F. Boyce, and L. Xing Tumor Necrosis Factor Promotes Runx2 Degradation through Up-regulation of Smurf1 and Smurf2 in Osteoblasts J. Biol. Chem., February 17, 2006; 281(7): 4326 - 4333. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Nair, M. Bischoff, M. M. Senn, and B. Berger-Bachi The {sigma}B Regulon Influences Internalization of Staphylococcus aureus by Osteoblasts Infect. Immun., July 1, 2003; 71(7): 4167 - 4170. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ahmed, S. Meghji, R. J. Williams, B. Henderson, J. H. Brock, and S. P. Nair Staphylococcus aureus Fibronectin Binding Proteins Are Essential for Internalization by Osteoblasts but Do Not Account for Differences in Intracellular Levels of Bacteria Infect. Immun., May 1, 2001; 69(5): 2872 - 2877. [Abstract] [Full Text] [PDF] |
||||

